Adding Docetaxel to Androgen-Deprivation Therapy in Newly Diagnosed Metastatic Prostate Cancer

被引：0
|
作者：
Vogelzang, Nicholas J. [1 ,2 ]
机构：
[1] Comprehens Canc Ctr, US Oncol Res, Las Vegas, NV 89169 USA
[2] Univ Nevada, Sch Med, Med, Las Vegas, NV 89154 USA
来源：
AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY | 2014年 / 10卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：10 / 11
页数：2
相关论文
共 50 条
  • [41] Re: Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer
    不详
    [J]. JOURNAL OF UROLOGY, 2021, 205 (01): : 303 - 304
  • [42] A meta-analysis of cardiovascular events in intermittent androgen-deprivation therapy versus continuous androgen-deprivation therapy for prostate cancer patients
    C Jin
    Y Fan
    Y Meng
    C Shen
    Y Wang
    S Hu
    C Cui
    T Xu
    W Yu
    J Jin
    [J]. Prostate Cancer and Prostatic Diseases, 2016, 19 : 333 - 339
  • [43] Docetaxel or abiraterone in addition to androgen deprivation therapy in metastatic castration-sensitive prostate cancer
    Bilgin, Burak
    Sendur, Mehmet A. N.
    Hizal, Mutlu
    Akinci, Muhammed Bulent
    Dede, Didem Sener
    Yalcin, Bulent
    [J]. FUTURE ONCOLOGY, 2017, 13 (22) : 1911 - 1913
  • [44] Effectiveness of Adding Docetaxel to Androgen Deprivation Therapy for Metastatic Hormone-Sensitive Prostate Cancer in Korean Real-World Practice
    Park, Kwonoh
    Kim, Jin Young
    Park, Inkeun
    Shin, Seong Hoon
    Lee, Hyo Jin
    Lee, Jae Lyun
    [J]. YONSEI MEDICAL JOURNAL, 2023, 64 (02) : 86 - 93
  • [45] Harms of Intermittent vs Continuous Androgen-Deprivation Therapy for Prostate Cancer
    Niraula, Saroj
    Tannock, Ian F.
    [J]. JAMA ONCOLOGY, 2016, 2 (04) : 461 - 462
  • [46] Re: Oral Relugolix for Androgen-deprivation Therapy in Advanced Prostate Cancer
    Chow, Alexander K.
    Vourganti, Srinivas
    Konety, Badrinath R.
    [J]. EUROPEAN UROLOGY, 2021, 80 (03) : 386 - 386
  • [47] Immediate versus deferred androgen-deprivation therapy for localized prostate cancer
    [J]. Nature Clinical Practice Urology, 2006, 3 (7): : 348 - 349
  • [48] Androgen-Deprivation Therapy Is More Than Palliation in Oligometastatic Prostate Cancer
    Cattrini, Carlo
    Zanardi, Elisa
    Boccardo, Francesco
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (22) : 2350 - +
  • [49] Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer
    Roe, Kathrine
    Mikalsen, Lars T. G.
    van der Kogel, Albert J.
    Bussink, Johan
    Lyng, Heidi
    Ree, Anne H.
    Marignol, Laure
    Olsen, Dag R.
    [J]. RADIATION ONCOLOGY, 2012, 7
  • [50] Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer
    Kathrine Røe
    Lars TG Mikalsen
    Albert J van der Kogel
    Johan Bussink
    Heidi Lyng
    Anne H Ree
    Laure Marignol
    Dag R Olsen
    [J]. Radiation Oncology, 7
12345